Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



Exciting News: Bristol Myers Squibb Named to Dow Jones Sustainability Index North America for Second Consecutive Year

January 14, 2025
Bristol Myers Squibb, a leading pharmaceutical company, has been recognized for its commitment to sustainability and named to the prestigious Dow Jones Sustainability Index North America for the second year in a row. This index recognizes companies that have demonstrated outstanding performance in environmental, social, and governance (ESG) practices. Bristol Myers Squibb's inclusion in this index highlights its dedication to making a positive impact on communities and the environment. With this achievement, the company continues to solidify its position as a leader in the pharmaceutical industry.

Find out how the BRISTOL-MYERS SQUIBB COMPANY rate is expected to change

Get Forecast for BMY

Investor opinions & comments:

I'm impressed by Bristol Myers Squibb's dedication to sustainability. It's inspiring to see companies taking responsibility for their impact on the environment and society
— from BudgetBrittany at 01-17-2025 18:04
I wonder how Bristol Myers Squibb measures its sustainability performance. It would be interesting to see some specific examples of their environmental and social initiatives
— from JosephMorris at 01-17-2025 08:56
I'm glad to see the pharmaceutical industry taking steps towards sustainability. This is a significant achievement for Bristol Myers Squibb and it gives me hope for the future
— from MoneyMark at 01-16-2025 20:34
Well done Bristol Myers Squibb! It's great to see a pharmaceutical company being recognized for its commitment to sustainability. Keep up the good work!
— from DividendDaisy at 01-16-2025 06:33
Congratulations to Bristol Myers Squibb! This is a great recognition of their efforts in sustainability. I'm excited to see more companies prioritizing ESG practices
— from SavingsSamantha at 01-16-2025 04:18
Being named to the Dow Jones Sustainability Index is a prestigious recognition, but I'd like to know more about the criteria for inclusion. How rigorous is the selection process?
— from InvestorIan at 01-15-2025 19:30
I'm skeptical about the pharmaceutical industry's commitment to sustainability. It would be interesting to see how Bristol Myers Squibb compares to other companies in the index
— from WealthyWillie at 01-15-2025 00:16
What a great accomplishment for Bristol Myers Squibb! Being recognized for their sustainability efforts shows that they are truly committed to making a positive impact. Well done!
— from MarketMason at 01-14-2025 21:49
Bristol Myers Squibb's dedication to sustainability is commendable. It's refreshing to see a company in the pharmaceutical industry making efforts to protect the environment and support communities
— from BenjaminParker at 01-14-2025 03:24
If you want to leave a comment, then you need Login or Register





Other news for BMY

BMYJune 23, 2025Bristol Myers Squibb NYSE:BMY Set to Revolutionize Cancer Treatment with Breakthrough Drug  ~1 min.

Bristol Myers Squibb Company, a leading pharmaceutical company, is on the verge of revolutionizing cancer treatment with its groundbreaking new drug....

BMYJune 12, 2025BMY: Bristol-Myers Squibb Co. Reports Positive Phase 3 Trial Results For Sotyktu  ~1 min.

Investors are taking notice of Bristol-Myers Squibb Company, as they have recently announced positive phase 3 trial results for their drug Sotyktu. This news has caused BMY shares to rise by 3....

BMYMay 14, 2025QuantWave Successfully Achieves Price Target Forecast for Bristol-Myers Squibb Company with 14.06% Profit  ~2 min.

QuantWave, an automated forecasting platform, recently celebrated a significant achievement in its analytics with the successful price target forecast for the stock of BRISTOL-MYERS SQUIBB COMPANY....

BMYMay 14, 2025BRISTOL-MYERS SQUIBB COMPANY Hits QuantWave Price Target with 13.0% Profit Margin  ~2 min.

On April 11, 2025, QuantWave, an automated forecasting platform, released a short signal for BRISTOL-MYERS SQUIBB COMPANY with a price target forecast of 44.12 $, indicating a 13....

BMYMay 8, 2025BRISTOL-MYERS SQUIBB COMPANY Hits Price Target as QuantWave Forecast Achieves 7.55% Profit  ~1 min.

BRISTOL-MYERS SQUIBB COMPANY has seen its stock reach the predicted price target set by QuantWave's automated forecasting platform....



Related news

ABTFebruary 22, 2025Abbott Laboratories: A Rising Star in the Pharmaceutical Industry  ~2 min.

Abbott Laboratories (NYSE: ABT) has been making significant progress in the pharmaceutical industry, positioning itself as one of the best drug stocks to buy now....

ZTSJanuary 2, 2025Zoetis Inc. Sees Promising Growth as it Leads the Pharmaceuticals Sector  ~2 min.

Pharmaceutical giant Zoetis Inc. (NYSE:ZTS) continues to impress investors with its consistent growth and market-leading position....

AZNDecember 7, 2024Why AstraZeneca PLC AZN is Revolutionizing the Pharmaceutical Industry  ~2 min.

AstraZeneca PLC AZN, a leading multinational pharmaceutical company, is making groundbreaking strides in the industry....

FMCJanuary 29, 2025FMC Corporation Announces Groundbreaking Innovations and Expands Market Reach  ~2 min.

FMC Corporation, a global sustainable solutions provider, has recently revealed groundbreaking innovations that revolutionize multiple industries....

REGNFebruary 10, 2025Regeneron Pharmaceuticals Inc REGN Q4 2024 Earnings Call Highlights: Strong Revenue Growth ... Yahoo Finance  ~1 min.

Regeneron Pharmaceuticals Inc. (REGN) recently held its Q4 2024 earnings call, highlighting strong revenue growth and positive developments in its portfolio....